Retatrutide is one of the most talked-about emerging weight management compounds, mainly because of its strong early trial results and its triple-hormone mechanism (GLP-1, GIP, and glucagon activity). A common question is: what is the retatrutide price per month?

The key point is simple: there is no official retail price yet because it is still an investigational medication and not FDA-approved.

? Retatrutide Price Per Month (Current Estimates)

Based on available compounding and research-market data, the monthly cost typically looks like this:

• Low dose (starting phase): ~$150–$250/month
• Moderate dose: ~$250–$400/month
• Higher/maintenance dose: ~$400–$650/month

Some compounding pharmacy breakdowns show similar ranges, with most users landing between:

• $200–$650 per month depending on dose and source

At higher dosing levels, total monthly cost can rise above $600–$800+ depending on vial usage and protocol.

? Why the Monthly Price Varies So Much

1. Dosage Level

Retatrutide is typically started at a low dose and increased over time.

• Lower dose = cheaper monthly cost
• Higher dose = more product used per month = higher cost

2. Source Type

Current access routes include:

• Compounding pharmacies (medically supervised, mid-range pricing)
• Research/gray-market supply (lower cost but unregulated)
• Clinical trials (usually free, but limited access)

3. No Official FDA Pricing

Because it is still in development:

• No insurance coverage
• No pharmacy retail pricing
• No standardized monthly cost

Everything currently available is estimated or experimental pricing.

4. Supply and Demand Pressure

Market pricing is unstable because:

• Demand is increasing rapidly
• Supply is limited
• Manufacturing is still scaling

? Expected Future Price After Approval

If retatrutide is eventually approved, analysts expect pricing similar to other GLP-1 drugs:

• Estimated $1,000–$1,500 per month (cash price)

With insurance or manufacturer programs, future real-world cost could be significantly lower for some patients, but cash pricing is expected to stay high initially.

⚖️ Retatrutide vs Other Weight Loss Medications

For context:

• Semaglutide (Wegovy): ~$1,300/month
• Tirzepatide (Zepbound): ~$1,000/month
• Expected retatrutide: ~$1,100–$1,500/month (post-approval estimate)

Even in today’s early access market, retatrutide is generally cheaper than future branded pricing but highly variable depending on source quality and dose.

⚠️ Important Reality Check

A few things to keep in mind:

• Prices online are not standardized or regulated
• Some listings reflect research-only material, not medical products
• Quality, purity, and legality can vary widely depending on source
• “Monthly cost” often depends heavily on personal dosing schedules

? Conclusion

The retatrutide price per month currently ranges widely from about $150 to $650+ depending on dose and source, with most real-world compounded estimates landing around $200–$500 per month.

Because it is still in clinical development, pricing remains unstable and unofficial. Once approved, the cost is expected to rise significantly into the $1,000+ per month range.

In short: today’s price is flexible and experimental, while future pricing is likely to be standardized—and much higher.